Palikhey, A. et al. 2022. Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitor Compared to Sulphonylurea in Type II Diabetes Patients Inadequately Controlled with Metformin Alone. Journal of Universal College of Medical Sciences. 10, 01 (Aug. 2022), 40–44. DOI:https://doi.org/10.3126/jucms.v10i01.47228.